This section provides resources for healthcare personnel who provide immunization services.
It's Federal Law - You Must Use Vaccine Information Statements (CDC web site) every time you give a vaccine.
- Instructions for the Use of Vaccine Information Statements (CDC web site)
- Translations of Vaccine Information Statements (Immunization Action Coalition web site)
HPV Champion Toolkit (AAP website)
Talking to Your Parents about the HPV Vaccine (AAP website)
Additional guidance for providers regarding 9-valent HPV vaccine use among persons who previously received 2-valent HPV or 4-valent HPV vaccine.
Meningococcal group B (MenB) vaccines now available through the VFC Program for ages 16–18 years (CDC web site) This includes adolescents and young adults who do not have a condition or are not in a situation which increases their risk for serogroup B meningococcal disease.
Meningococcal B Recommendations for Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease (CDC web site)
Recommended Immunization Schedules - United States 2017
ACIP Recommendations (CDC web site)
Questions and Answers on the right are adapted from "Ask the Experts: CDC answers questions" acquired on 2-28-2013. We thank the Immunization Action Coalition.
Satellite broadcasts and web casts - Available on DVD and as archived web casts. Continuing education available (CME, CNE, CEU, CECH for Health Educators).
- “You Call the Shots” Centers for Disease Control and Prevention (CDC web site)
- The Immunization Encounter: Critical Issues (CDC web site) 2-½ hours, view the archived web cast.
- Epidemiology and Prevention of Vaccine-Preventable Diseases (CDC web site)
- Adult Immunization Update (CDC web site) 2-½ hours; view the archived web cast from 2006
- Current Issues Netconferences (CDC web site)
- Medical Assistants Resources and Training in Immunizations (MARTi web site)
Additional Free Online Continuing Education Resources for Vaccine Providers
- Teaching Immunization Delivery and Evaluation (TIDE web site sponsored by the Medical University of South Carolina)
- See the new TIDE Vaccine Safety Module! This module is designed to help you explain the dangers of vaccine-preventable diseases and the effectiveness of vaccines against them, as well as answering parents' common vaccine safety questions.
- Centers for Disease Control and Prevention
- Teaching Immunization for Medical Education This curriculum is designed for use in medical schools to support immunization instruction. The materials provide student objectives, learning objectives, key teaching points, and resources.
CE Credit for Physicians
- Building an Adult Immunization Practice: The Primary Care Physician's Role in Disease Prevention (National Foundation for Infectious Diseases - NFID web site)
- NFID Adult Immunization CME Learning Center on Medscape (Medscape web site)
CE Credit for Nurses
- Free Immunization Continuing Education Credit through Nip-It (Nursing Initiative Promoting Immunization Training web site)
- General Recommendations on Immunization (CDC web site) Every office needs a copy!
Need a printed copy? ACIP Recommendations can be ordered online at no charge (CDC web site)
- Vaccination Criteria for U.S. Immigration (CDC web site)
- Great Schedule to Give to Parents: Online Personalized Immunization Scheduler for Children Birth through Six Years (CDC web site)
For Vaccine Providers
- Epidemiology and Prevention of Vaccine-Preventable Diseases: Also known as the “Pink Book” (CDC web site)
- Summary of Recommendations for Childhood and Adolescent Immunization (Immunization Action Coalition web site)
- Summary of Recommendations for Adult Immunizations (Immunization Action Coalition web site)
- Storage and Handling of Immunobiologics - pages 17 through 19 of General Recommendations (CDC web site)
- Vaccine Storage & Handling Toolkit (CDC website)
- Checklist for Safe Vaccine Storage (Immunization Action Coalition web site)
- Don’t Be Guilty of These Errors in Vaccine Storage and Handling
- Temperature Logs
- Clinic Supplies Checklist
- Emergency Protocols – CPR: Clinical staff should receive annual CPR certification.
- The American Heart Association online is a resource.
- Emergency Protocols - Anaphylaxis: Clinics should have a protocol in place for emergencies.
- Vaccination Records: See page 30 in the General Recommendations (CDC web site)
- Provider Records:
- Vaccine Administration Record For Children and Teens (Immunization Action Coalition web site) and
- Vaccine Administration Record For Adults (Immunization Action Coalition web site).
- Personal Immunization Record: Patients or parents should always be given a personal immunization record. All vaccine providers may order a supply of Oklahoma’s Official Immunization Record Card (OSDH Form No. 218B) by calling the Oklahoma State Dept. of Health Shipping and Receiving Department at (405) 271-1777.
- Provider Records:
- Immunization Registry: The Oklahoma State Immunization Information System (OSIIS) is available to all providers who have Internet access. Find out more about OSIIS in the Oklahoma State Immunization Information System section of this web site.
- Vaccines for Children Program Information (CDC web site)
Every person who administers vaccines should screen every patient for contraindications and precautions before giving vaccines.
Effective screening is key to preventing serious adverse events and is not difficult or complicated. Screening can be accomplished with just a few questions (See the screening forms which follow).
The "Contraindications and Precautions" section in the General Recommendations (CDC web site), pages 40 through 43, describes valid and invalid contraindications and precautions.
- Screening Questionnaire – Children and Teens (Immunization Action Coalition - IAC - web site): Child and teen immunization screening tool, developed by the IAC, includes rationale for screening questions.
- Screening Questionnaire for Adults (IAC web site): Adult immunization screening tool, developed by the IAC, includes rationale for the screening questions.
- Quick Guide to Contraindications to Vaccinations (IAC web site): Designed to help vaccine providers determine what common and uncommon symptoms and conditions are contraindications and which ones are not.
More specific information on contraindications and precautions is available in vaccine-specific ACIP recommendations.
- Comforting Restraint
- Immunization Site Maps: Where to give multiple doses.
- Administering Vaccines: Dose, Route, Site, and Needle Size
- The "Vaccine Administration" section in the General Recommendations, pages 13 through 16.
- Store vaccines properly.
- Distribute Vaccine Information Statements to parents or vaccine recipients prior to administration of each dose of vaccine and answer all patient and parent questions.
- Administer vaccines correctly including proper dose, route, site, and needle size.
- Screen patients for and observe valid precautions and contraindications.
- Follow current recommended immunization schedules for children, adolescents and adults, including proper timing and spacing of vaccine doses.
- Manage vaccine side effects using your best clinical judgment.
- Have procedures in place and be prepared for emergency care of a person who experiences an anaphylactic reaction.
- Report suspected side effects to the Vaccine Adverse Event Reporting System (VAERS).
- Follow federal requirements for recording vaccines administered.
Resources for Conversations with Parents
- Talking with Parents about Vaccines for Infants (CDC web site)
- Understanding MMR Vaccine Safety
- If You Choose Not to Vaccinate Your Child Understand the Risks and Responsibilities (CDC web site download)
Oklahoma Immunization Update
January 2015 Oklahoma Immunization Update
February 2015 Oklahoma Immunization Update
March 2015 Oklahoma Immunization Update
April 2015 Oklahoma Immunization Update
May 2015 Oklahoma Immunization Update
June 2015 Oklahoma Immunization Update
July 2015 Oklahoma Immunization Update
August 2015 Oklahoma Immunization Update
September 2015 Oklahoma Immunization Update
October 2015 Oklahoma Immunization Update
November 2015 Oklahoma Immunization Update
December 2015 Oklahoma Immunization Update
A: The new ACIP recommendations are that pregnant women receive Tdap vaccine during each pregnancy, even if they have received Tdap previously. Women who have never received Tdap and who do not receive it during pregnancy should receive it immediately postpartum.
Q: If a woman did not receive Tdap during pregnancy, and it is uncertain whether she received a dose of Tdap prior to her pregnancy, should she receive a dose of Tdap postpartum?
A: Yes. If there is no written documentation that she received a dose of Tdap prior to or during pregnancy, a dose of Tdap should be administered to her immediately postpartum.
Q: A 7-year-old who needed a tetanus shot for wound management came into our emergency department. My question is, if a child has received the complete 5-dose series of DTaP but has never had Tdap, should the child receive Tdap or Td for wound management?
A: Neither. A child who has completed 5 doses of DTaP has by definition received the fifth dose on or after his/her fourth birthday. In this child's case, it has been less than four years since receipt of the complete series, so the child does not need either Tdap or Td. The child is fully vaccinated against tetanus according to CDC tetanus wound management guidelines.
Q: What are the new ACIP recommendations for use of MenHibrix, the new combination meningococcal Groups C and Y and Haemophilus influenzae type b vaccine?
A: Licensed in June 2012, MenHibrix (Hib-MenCY; GSK) is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b. This vaccine does not protect against meningococcal serogroups A, B, and W135. In October 2012, ACIP voted to recommend that infants at increased risk for meningococcal disease be vaccinated with 4 doses of Hib-MenCY at age 2, 4, 6, and 12 through 15 months. This includes infants with recognized persistent complement pathway deficiencies and infants who have anatomic or functional asplenia, including sickle cell disease. You can find this in footnote #13 of the "Recommended Immunization Schedule for Persons Aged 0 Through 18 Years - United States, 2013". Hib-MenCY can be used in infants age 2 through 18 months who live in communities with serogroup C and Y meningococcal disease outbreaks.